Drug therapy for the prevention and treatment of bronchopulmonary dysplasia-Reference-Cited by-同舟云学术

Drug therapy for the prevention and treatment of bronchopulmonary dysplasia

Published:2015-02-16 Issue: Volume:6 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Iyengar Anjali,Davis Jonathan M.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference87 articles.

1. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease.;Afshar;Am. J. Physiol. Lung Cell. Mol. Physiol.,2003

2. Pentoxifylline and prevention of hyperoxia-induced lung injury in neonatal rats.;Almario;Pediatr. Res.,2012

3. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.;Ambalavanan;Pediatrics,2005

4. Morphologic alterations in the trachea and the salivary gland following the induction of rapid synchronous vitamin A deficiency in rats.;Anzano;Am. J. Pathol.,1980

5. Caffeine impact on neonatal morbidities.;Aranda;J. Matern. Fetal Neonatal Med.,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theophylline impact on weaning in oxygen-dependent infants followed in an outpatient Kangaroo Program;Frontiers in Pediatrics;2024-08-20

2. Strategies for the prevention of bronchopulmonary dysplasia;Frontiers in Pediatrics;2024-07-24

3. Comparison of different definitions of bronchopulmonary dysplasia based on the prediction of adverse outcomes: Followed up to 18-24 months corrected age;2022-08-29

4. Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?;Frontiers in Pediatrics;2022-03-09

5. Etiology and Pathogenesis;Manual of Neonatal Respiratory Care;2022